Protean BioDiagnostics to Launch HistoAI in Conjunction with Nucleai as a New AI Based Service

Protean Launches new AI product line for assisting prostate pathologists.

 
histoai.png
 

Protean BioDiagnostics has collaborated with Nucleai to create a new Artificial Intelligence based product, HistoAI, for improving the efficiency and accuracy of Prostate Cancer pathology diagnosis. The AI powered Protean BioDiagnostics service will assist urologists and pathologists by analyzing digital images of whole slide scans of prostate core biopsies to rapidly identify and grade areas of prostatic carcinoma reducing the risk of diagnostic error.

Anthony Magliocco